Literature DB >> 28643124

[Solid pediatric tumors : A brief survey of the rarity cabinet].

B Gürtl-Lackner1,2, D Gisselsson-Nord3, G Vujanic4.   

Abstract

Solid tumors in childhood are extremely rare entities, which are usually treated in specialized centers. Diagnosis and therapy are carried out according to a joint European protocol, whereby the pathological evaluation and therapy are carried out according to international guidelines. For the correct diagnosis and/or therapy of most tumors, analysis of specific genetic changes is mandatory; therefore, tumors have to be adequately sampled for parallel genetic analysis during the pathological work-up. A second opinion reference of the histopathological assessment is part of the international guidelines. Neuroblastomas, congenital mesoblastic nephromas and rhabdoid tumors are examples of solid tumors in childhood that are not restricted to one organ and occur exclusively during childhood.

Entities:  

Keywords:  Congenital mesoblastic nephroma; INI1/SMARCB1; MYC-N; Neuroblastoma; Rhabdoid tumors

Mesh:

Substances:

Year:  2017        PMID: 28643124     DOI: 10.1007/s00292-017-0312-y

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  32 in total

1.  Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors.

Authors:  P Argani; M Fritsch; S S Kadkol; A Schuster; J B Beckwith; E J Perlman
Journal:  Mod Pathol       Date:  2000-01       Impact factor: 7.842

2.  International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Authors:  H Shimada; S Umehara; Y Monobe; Y Hachitanda; A Nakagawa; S Goto; R B Gerbing; D O Stram; J N Lukens; K K Matthay
Journal:  Cancer       Date:  2001-11-01       Impact factor: 6.860

3.  Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.

Authors:  H Shimada; I M Ambros; L P Dehner; J Hata; V V Joshi; B Roald
Journal:  Cancer       Date:  1999-07-15       Impact factor: 6.860

Review 4.  Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center.

Authors:  D A Weeks; J B Beckwith; G W Mierau; D W Luckey
Journal:  Am J Surg Pathol       Date:  1989-06       Impact factor: 6.394

Review 5.  Recent advances in pediatric renal neoplasia.

Authors:  Pedram Argani; Marc Ladanyi
Journal:  Adv Anat Pathol       Date:  2003-09       Impact factor: 3.875

6.  MYCN-status in neuroblastoma: characteristics of tumours showing amplification, gain, and non-amplification.

Authors:  Ruediger Spitz; B Hero; M Skowron; K Ernestus; F Berthold
Journal:  Eur J Cancer       Date:  2004-12       Impact factor: 9.162

7.  Renal and extrarenal rhabdoid tumors in children: a clinicopathologic study of 14 patients.

Authors:  C Sotelo-Avila; F Gonzalez-Crussi; D deMello; C Vogler; W M Gooch; G Gale; R Pena
Journal:  Semin Diagn Pathol       Date:  1986-05       Impact factor: 3.464

8.  Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular.

Authors:  Michel Peuchmaur; Emanuele S G d'Amore; Vijay V Joshi; Jun-ichi Hata; Borghild Roald; Louis P Dehner; Robert B Gerbing; Daniel O Stram; John N Lukens; Katherine K Matthay; Hiroyuki Shimada
Journal:  Cancer       Date:  2003-11-15       Impact factor: 6.860

9.  Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.

Authors:  B P Rubin; C J Chen; T W Morgan; S Xiao; H E Grier; H P Kozakewich; A R Perez-Atayde; J A Fletcher
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer.

Authors:  I Versteege; N Sévenet; J Lange; M F Rousseau-Merck; P Ambros; R Handgretinger; A Aurias; O Delattre
Journal:  Nature       Date:  1998-07-09       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.